NCT03847311 2025-01-09
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
University of Arizona
Phase 2 Completed
University of Arizona
Haukeland University Hospital
Sanofi
St. James's Hospital, Ireland
Alliance for Clinical Trials in Oncology
University of Alabama at Birmingham
Medical University of Vienna